Topic

RAPT

A collection of 1 issue

Rapt Therapeutics Upgraded to Buy by H.C. Wainwright

Rapt Therapeutics sees a positive upgrade to Buy by H.C. Wainwright following a new licensing agreement for its lead product, boosting investor confidence.